Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-333,880
Closed -$4.27M 762
2025
Q2
$4.27M Buy
333,880
+67,877
+26% +$814K 0.01% 591
2025
Q1
$2.74M Buy
266,003
+245,798
+1,217% +$3.16M 0.01% 677
2024
Q4
$257K Sell
20,205
-386
-2% -$5.1K ﹤0.01% 1008
2024
Q3
$264K Sell
20,591
-32,425
-61% -$397K ﹤0.01% 1024
2024
Q2
$672K Buy
53,016
+25,094
+90% +$434K ﹤0.01% 920
2024
Q1
$633K Sell
27,922
-16,037
-36% -$375K ﹤0.01% 910
2023
Q4
$1.09M Buy
+43,959
New +$858K ﹤0.01% 834

Other funds holding PATH

Axa's PATH Position: Q3 2025 in Review

Axa sold out of UiPath (PATH) in Q3 2025, closing a stake of 333,880 shares — an estimated $4.27M sold.

Axa first reported a position in PATH in Q4 2023 and held it in 7 quarters. The position peaked at $4.27M in Q2 2025. 473 funds tracked by Wall St. Rank hold PATH as of Q3 2025.

  • Axa reported no remaining UiPath position as of Q3 2025 after selling out during the quarter.
  • Axa sold 333,880 UiPath shares in Q3 2025, an estimated $4.27M.
  • Axa first reported a position in UiPath in Q4 2023 and held it in 7 quarters.
  • Axa's UiPath position peaked at $4.27M in Q2 2025.
  • 473 funds tracked by Wall St. Rank held UiPath as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.